Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage (vol 12, pg 1225, 2019)

被引：1
|
作者：
Wilke, T.
Picker, N.
Mueller, S.
机构：
来源：
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY | 2019年 / 12卷
关键词：
D O I：
10.2147/DMSO.S225508
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1397 / 1397
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD INSULIN THERAPY IN GERMAN TYPE 2 DIABETES MELLITUS PATIENTS: PATIENT CHARACTERISTICS, TREATMENT PATTERNS AND INSULIN DOSAGE
    Gabler, M.
    Geier, S.
    Foersch, J.
    Picker, N.
    Mueller, S.
    Aberle, J.
    Martin, S.
    Riedl, M.
    Wilke, T.
    [J]. VALUE IN HEALTH, 2019, 22 : S594 - S595
  • [2] Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
    Wilke, Thomas
    Picker, Nils
    Mueller, Sabrina
    Geier, Silke
    Foersch, Johannes
    Aberle, Jens
    Martin, Stephan
    Riedl, Matthias
    Gabler, Maximilian
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2019, 12 : 1225 - 1237
  • [3] Real-world treatment switching patterns in patients (pts) with type 2 diabetes mellitus (T2DM) on basal insulin (INS)
    Kapustin, J.
    Anderson, J. E.
    Reid, T.
    Rhinehart, A.
    Brunton, S.
    Stewart, J.
    Zhou, W.
    Dex, T.
    Kazemi, M.
    Vlajnic, A.
    Dalal, M.
    [J]. DIABETOLOGIA, 2014, 57 : S440 - S440
  • [4] Type 1 Diabetes: Real-World Insulin Injection Patterns
    Catrina, Sergiu-Bogdan
    Hartvig, Niels V.
    Kaas, Anne
    Moller, Jonas
    Mardby, Ann-Charlotte M.
    Jendle, Johan H.
    [J]. DIABETES, 2020, 69
  • [5] Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review
    Davies, M. J.
    Gagliardino, J. J.
    Gray, L. J.
    Khunti, K.
    Mohan, V.
    Hughes, R.
    [J]. DIABETIC MEDICINE, 2013, 30 (05) : 512 - 524
  • [6] Real-world clinical outcomes and costs in type 2 diabetes mellitus patients after initiation of insulin therapy: A German claims data analysis
    Gabler, Maximilian
    Picker, Nils
    Geier, Silke
    Foersch, Johannes
    Aberle, Jens
    Martin, Stephan
    Riedl, Matthias
    Wilke, Thomas
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
  • [7] Starting Insulin in Type 2 Diabetes: Real-World Outcomes After the First 12 Months of Insulin Therapy in a New Zealand Cohort (vol 6, pg 49, 2015)
    Sehgal, Shekhar
    Khanolkar, Manish
    [J]. DIABETES THERAPY, 2015, 6 (01) : 99 - 99
  • [8] Reasons for discontinuing insulin and factors associated with insulin discontinuation in patients with type 2 diabetes mellitus: a real-world evidence study
    Jianmin Wu
    Fritha Morrison
    Zhenxiang Zhao
    Ginger Haynes
    Xuanyao He
    Ayad K. Ali
    Maria Shubina
    Shervin Malmasi
    Wendong Ge
    Xiaomei Peng
    Alexander Turchin
    [J]. Clinical Diabetes and Endocrinology, 7 (1)
  • [9] Real-World Use of Canagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Harris, Stewart B.
    Reichert, Sonja
    Mequanint, Selam M.
    Spaic, Tamara
    Esler, Jim
    [J]. DIABETES, 2017, 66 : A328 - A329
  • [10] Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
    Levin, Philip
    Wei, Wenhui
    Wang, Li
    Pan, Chunshen
    Douglas, Damon
    Baser, Onur
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 439 - 446
12345